METASTATIC CHOLANGIOCARCINOMA
Clinical trials for METASTATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted pill outperform chemo for bile duct cancer?
Disease control TerminatedThis trial is testing whether the targeted drug pemigatinib can slow or shrink a specific type of bile duct cancer (cholangiocarcinoma) that has a genetic change called FGFR2 rearrangement and cannot be removed by surgery. Participants will receive either pemigatinib as a daily p…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Experimental bile duct cancer drug tested in tiny trial – already halted
Disease control TerminatedThis early-stage trial tested a new drug called NXP800 in 7 people with advanced bile duct cancer that had spread or stopped responding to treatment. The goal was to find a safe dose and see if the drug could shrink tumors by blocking a protein linked to cancer growth. However, t…
Matched conditions: METASTATIC CHOLANGIOCARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC